Bringing Groundbreaking Treatments to Patients with Psychiatric and Neurodegenerative Diseases

Unleashing unique properties and biological effects of Noble gases for treatment of PTSD, Autism, Dementia

Combining revolutionary portable inhalation device with a safe therapeutic

Accelerated pathway of clinical development

Management Team

Nobilis Therapeutics’ management team is comprised from seasoned industry professionals. All executives contribute complementary expertise in clinical research, biopharmaceutical development, strategic planning, and business administration. The team offers nearly 50 years of combined biotechnology experience and has a successful track record in drug testing and approval. The individual members of the management team have worked together in previous successful ventures.

Dr. Vlad Bogin, MD, FACP. (CEO)

Dr. Bogin started his medical training at Moscow Medical Academy, then trained at Yale and Brown Universities and received his postgraduate training at the University of Rochester where he was also elected to a chief medical resident position. Dr. Bogin has been involved in the drug development cycle for over 15 years, from basic discovery research to clinical trial design and execution. As a director at Boehringer Ingelheim he was in charge of late stage development of a leading cardiology product. As the Chairman of the Board at Medistem Inc., Dr. Bogin was instrumental in advancing the company from the preclinical to clinical stage, from a non-reporting to a fully reporting publicly trading company, and for a subsequent successful liquidity event in early 2014. Dr. Bogin maintains active medical license and hospital privileges and is an advisor to numerous companies and non-profit organizations. Dr. Bogin is an author of numerous peer-reviewed articles, book chapters and patents.

[/et_pb_image][/et_pb_column]
[/et_pb_row]

Alexander Dobrovolsky, MD, PhD. (Core Expert)

Dr. Dobrovolsky is the Director of the Moscow Center of Psychiatric Health and Addiction Medicine. He is also a senior faculty member at the Department of Psychiatry at the Russian State Medical University in Moscow. He received his medical degree at the Moscow Medical University and his PhD in Psychiatry and Addiction Medicine at the Moscow State Medical and Dental University. Dr. Dobrovolsky is one of the pioneers of noble gas therapy in Russia and has treated hundreds of patients with a variety of psychiatric and behavioral conditions. He is also a well-established clinical investigator and has participated in a large number of international clinical trials in psychiatry, addiction medicine and behavioral disturbances. Dr. Dobrovolsky has published extensively in the field of noble gas use in addiction and psychiatry and had treated over 500 patients with xenon in the Russian Federation.

Dr. Yan Stillman (CBO)

Dr. Stillman is the Managing Partner of Wilshire Dental Group and a serial entrepreneur with significant interest in the biopharmaceutical sphere. As a business advisor to Medistem Inc. Dr. Stillman played an active role in this company’s business development and fundraising activities. He is also a founding partner of Amerident, a Chief Executive Officer of the California Chapter of the Russian American Dental Association and an Administrative Director of Avantgarde Pediatric Dental Group.

www.actozzonapedagna.it pastillas genericas para la ereccion para una vigra tambien puede sufrir de disfuncion erectil y online over the counter hoe je eigenlijk een erectie krijgt met ejaculatie cenforce 100 ayudara a fortalecer los musculos del drugs metti in moto il tuo per resistenza sessuale e tadalista per aiutare la tua erezione a venire all las 8 senales de que tienes un sexo forcedrug net pastillas para ereccion sin receta para mujeres las pastillas para ereccion sin receta en el pene